Familial mediterranean fever laboratory findings: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Familial mediterranean fever}} | {{Familial mediterranean fever}} | ||
{{CMG}} | {{CMG}} {{AE}} {{Sahar}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 02:22, 4 June 2019
|
Familial Mediterranean Fever Microchapters |
|
Differentiating Familial Mediterranean Fever from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Familial mediterranean fever laboratory findings On the Web |
|
American Roentgen Ray Society Images of Familial mediterranean fever laboratory findings |
|
Familial mediterranean fever laboratory findings in the news |
|
Directions to Hospitals Treating Familial mediterranean fever |
|
Risk calculators and risk factors for Familial mediterranean fever laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
An acute phase response is present during attacks, with high C-reactive protein levels, an elevated white blood cell count and other markers of inflammation. In patients with a long history of attacks, monitoring the renal function is of importance in predicting chronic renal failure.[1]
Laboratory Findings
There are no diagnostic laboratory findings associated with familial Mediterranean fever. However, this disorder is associated with an increase in acute phase reactant such as:[2]
References
- ↑ Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 2000;14(3):477-98. PMID 10985982.
- ↑ Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (January 2002). "Acute phase response in familial Mediterranean fever". Ann. Rheum. Dis. 61 (1): 79–81. doi:10.1136/ard.61.1.79. PMC 1753891. PMID 11779767.